Udveje Behandling Aps: Financial statements 2023
CVR: 40518916
Source: annual report 2023, Danish Business Authority
01/10/2022 – 30/09/2023
Udveje Behandling Aps (CVR 40518916) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 4,873,418 and a net result of DKK 710,064 compared with DKK 236,798 the year before. That is an increase of 148.1% compared with the year before. Equity in the 2023 report amounted to DKK 774,575. The solvency ratio was 30.3%. The company had 7 employees in the financial year.
- Gross Profit
- DKK 4,873,418
- Profit/Loss
- DKK 710,064
- Equity
- DKK 774,575
- Total Assets
- DKK 2,557,398
- Employees
- 7
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 4.9M | 710K | 775K | 7 |
| 2022 | - | 2M | 237K | 445K | - |
| 2021 | - | 1.1M | 222K | 208K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of May 24, 2023, Kirsten Benediktson has joined the board of directors of Udveje Behandling Aps.
As of May 24, 2023, Michael Mølgaard has joined the board of directors of Udveje Behandling Aps.
As of May 24, 2023, Chit Calopez Lodberg has joined the board of directors of Udveje Behandling Aps.
As of May 24, 2023, Tanja Schlein Andersen has left the board of directors of Udveje Behandling Aps.
As of May 24, 2023, Kenn Vagn Thomsen has left the board of directors of Udveje Behandling Aps.
As of May 24, 2023, Ole Vedel Rasmussen has left the board of directors of Udveje Behandling Aps.
Udveje Behandling Aps has published its annual report for 2022. Gross profit came to DKK 1,964,105, and the net result was DKK 236,798.
About Udveje Behandling Aps
Udveje Behandling Aps is a Danish company of the type Anpartsselskab based in Store Merløse, founded in 2019. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named Udveje ApS. The management consists of John Kastrup. The board consists of Rolf Nolsøe Bau (chair), Chit Calopez Lodberg, Claus Christiansen and Kirsten Benediktson. The company is owned by UDVEJE Holding ApS. The company has 17 employees (2026). In 2025, the company reported a gross profit of DKK 4,937,535 and a net result of DKK 64,996 compared with DKK 541,297 the year before. Equity in the 2025 report amounted to DKK 675,868.